Poseida Therapeutics Inc (PSTX)
2.705
-0.22
(-7.68%)
USD |
NASDAQ |
May 08, 16:00
2.705
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Price to Book Value: 2.517 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 07, 2024 | 2.726 |
May 06, 2024 | 2.633 |
May 03, 2024 | 2.670 |
May 02, 2024 | 2.596 |
May 01, 2024 | 2.577 |
April 30, 2024 | 2.252 |
April 29, 2024 | 2.159 |
April 26, 2024 | 1.982 |
April 25, 2024 | 1.907 |
April 24, 2024 | 1.926 |
April 23, 2024 | 2.010 |
April 22, 2024 | 2.005 |
April 19, 2024 | 1.880 |
April 18, 2024 | 1.861 |
April 17, 2024 | 1.898 |
April 16, 2024 | 1.889 |
April 15, 2024 | 2.261 |
April 12, 2024 | 2.540 |
April 11, 2024 | 2.708 |
April 10, 2024 | 2.596 |
April 09, 2024 | 2.801 |
April 08, 2024 | 2.764 |
April 05, 2024 | 2.782 |
April 04, 2024 | 2.856 |
April 03, 2024 | 2.847 |
Date | Value |
---|---|
April 02, 2024 | 2.698 |
April 01, 2024 | 2.884 |
March 28, 2024 | 2.968 |
March 27, 2024 | 2.866 |
March 26, 2024 | 2.615 |
March 25, 2024 | 2.829 |
March 22, 2024 | 2.894 |
March 21, 2024 | 2.829 |
March 20, 2024 | 2.764 |
March 19, 2024 | 2.708 |
March 18, 2024 | 2.847 |
March 15, 2024 | 2.996 |
March 14, 2024 | 3.015 |
March 13, 2024 | 3.173 |
March 12, 2024 | 2.950 |
March 11, 2024 | 3.173 |
March 08, 2024 | 3.787 |
March 07, 2024 | 3.192 |
March 06, 2024 | 3.340 |
March 05, 2024 | 3.238 |
March 04, 2024 | 3.429 |
March 01, 2024 | 3.809 |
February 29, 2024 | 3.652 |
February 28, 2024 | 3.431 |
February 27, 2024 | 3.477 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9142
Minimum
Jun 29 2023
5.736
Maximum
Aug 12 2022
2.331
Average
2.308
Median
May 04 2021
Price to Book Value Benchmarks
Biomea Fusion Inc | 2.938 |
Cartesian Therapeutics Inc | -- |
Lantern Pharma Inc | 1.701 |
NovaBay Pharmaceuticals Inc | 1.933 |
Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 3.770 |
PEG Ratio | -0.0737 |
Price | 2.705 |
Earnings Yield | -51.02% |
Market Cap | 261.00M |
PEGY Ratio | -0.0737 |